Focal segmental glomerulosclerosis classification: Difference between revisions
Olufunmilola (talk | contribs) No edit summary |
Olufunmilola (talk | contribs) No edit summary |
||
| Line 10: | Line 10: | ||
Secondary FSGS is better described. It often occurs from some glomerular injury from previous glomeruli injury and hypertrophy. Secondary FSGS presents with non-nephrotic proteinuria and with some renal insufficiency. Etiologies of Secondary FSGS include: | Secondary FSGS is better described. It often occurs from some glomerular injury from previous glomeruli injury and hypertrophy. Secondary FSGS presents with non-nephrotic proteinuria and with some renal insufficiency. Etiologies of Secondary FSGS include: | ||
•Infections with HIV, HBV; | |||
•Drugs like anabolic steroids, heroin, lithium, pamidronate, analgesics as well as | |||
•Conditions like sickle cell disease and obesity. | |||
•Systemic diseases like SLE, Lupus Nephritis, IgA Nephropathy that can cause glomerular scarring can cause Secondary FSGS. | |||
•Genetic mutations with familial mode of inheritance had also been implicated in Secondary FSGS. | |||
Revision as of 14:48, 20 October 2016
|
Focal segmental glomerulosclerosis Microchapters |
|
Differentiating Focal segmental glomerulosclerosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Focal segmental glomerulosclerosis classification On the Web |
|
American Roentgen Ray Society Images of Focal segmental glomerulosclerosis classification |
|
Focal segmental glomerulosclerosis classification in the news |
|
Directions to Hospitals Treating Focal segmental glomerulosclerosis |
|
Risk calculators and risk factors for Focal segmental glomerulosclerosis classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2]Associate Editor-In-Chief:’’’ Olufunmilola Olubukola M.D.[3]
Overview
Classification
FSGS can be classified as primary or secondary disease depending etiology and the course of disease. The primary cause of FSGS is unknown or idiopathic, but there are several postulations as probable causes. 80% of FSGS cases are idiopathic. Primary or Idiopathic FSGS often presents with features of Nephrotic Syndrome with associated hematuria (microscopic), hypertension and renal insufficiency. Some genetic mutations had been associated with familial idiopathic FSGS. The role of over-expression of inflammatory markers like Tumor Necrosis Factor (TNF), Interleukins had also been associated with the extent of glomerular sclerosis.[1]
Secondary FSGS is better described. It often occurs from some glomerular injury from previous glomeruli injury and hypertrophy. Secondary FSGS presents with non-nephrotic proteinuria and with some renal insufficiency. Etiologies of Secondary FSGS include: •Infections with HIV, HBV; •Drugs like anabolic steroids, heroin, lithium, pamidronate, analgesics as well as •Conditions like sickle cell disease and obesity. •Systemic diseases like SLE, Lupus Nephritis, IgA Nephropathy that can cause glomerular scarring can cause Secondary FSGS. •Genetic mutations with familial mode of inheritance had also been implicated in Secondary FSGS.
Based on the proposed Columbia classification by D’Agati and colleagues[2] in 2004, the classification of focal segmental glomerulosclerosis (FSGS) based on the morphology is as follows:
| Variant | Location of Lesion | Distribution of Lesion | Characteristic Features |
| Not Otherwise Specified (NOS) | Anywhere | Segmental | Capillary lumen abolished by the segmental increase in matrix. |
| Perihilar Variant | Perihilar | Segmental | Presence of one or more glomeruli containing hyalinosis in the perihilar regions with or without sclerosis. Within each glomerulus, the segmental lesions must contain > 50% perihilar hyalinosis and/or sclerosis. |
| Cellular Variant | Anywhere | Segmental | Presence of one or more glomerulus with segmental hypercellularity of the capillary endothelium that blocks the capillary lumen, with or without foam cells and/or karryohexis. |
| Tip Variant | At tip domain | Segmental | One or more segmental lesions, that include tip domains. Lesions must have adhesions/confluence of podocytes with parietal or tubular cells. Tip domains are defined as 25% of tuft adjacent to the origin of the proximal tubule. Sclerosing lesions shuld be <25% of tuft, while cellular lesions should be < 50% of tuft. No perihilar sclerosis should be observed. |
| Collapsing Variant | Anywhere | Segmental or global | One or more glomeruli with collapse with evidence of podocyte hypertrophy and hyperplasia. |
References
- ↑ Kang DH, Joly AH, Oh SW, Hugo C, Kerjaschki D, Gordon KL; et al. (2001). "Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1". J Am Soc Nephrol. 12 (7): 1434–47. PMID 11423572 PMID 11423572 Check
|pmid=value (help). - ↑ 2.0 2.1 D'Agati VD, Fogo AB, Bruijn JA, Jennette JC (2004). "Pathologic classification of focal segmental glomerulosclerosis: a working proposal". Am J Kidney Dis. 43 (2): 368–82. PMID 14750104.